Filing Details

Accession Number:
0001572426-16-000158
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-02-22 19:43:42
Reporting Period:
2016-02-18
Filing Date:
2016-02-22
Accepted Time:
2016-02-22 19:43:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1618561 Nexvet Biopharma Plc NVET () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1560864 T. Damian Lismore C/O Nexvet Biopharma Plc
Unit 5, Sragh Technology Park, Rahan Rd
Tullamore L2 R35 FR98
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2016-02-18 5,000 $3.22 18,724 No 4 P Indirect Glenariff Superannuation Pty Ltd <Glenariff Super Fund A/C>
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Glenariff Superannuation Pty Ltd <Glenariff Super Fund A/C>
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 16,000 Direct
Ordinary Shares 14,160 Indirect By Spouse
Footnotes
  1. Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $3.19 to $3.29, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  2. The reporting person and his spouse share voting and dispositive power with respect to these reported securities.